Dr. Thomas Lynch is Professor of Medicine at Harvard Medical School, Director of the Oncology Service Line at Dana-Farber Partners CancerCare and Chief of Hematology-Oncology at the Massachusetts General Hospital Cancer Center in Boston, Massachusetts. Dr. Lynch discusses why Schwartz Center Rounds are so successful.
Schwartz Center Rounds at Massachusetts General Hospital

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Thomas Lynch is Professor of Medicine at Harvard Medical School, Director of the Oncology Service Line at Dana-Farber Partners CancerCare and Chief of Hematology-Oncology at the Massachusetts General Hospital Cancer Center in Boston, Massachusetts. Dr. Lynch discusses why Schwartz Center Rounds are so successful.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Level Up Your Skills: Tailoring Management of HF
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?